Joy Ventures News Today

GrayMatters received US FDA approval for marketing its technology in March and after the start of the Israel-Hamas war received approval in Israel.

Corundum Neuroscience aunches a new neuroscience-focused venture builder and fund to spur neuroscience research and innovation.

- Jim Schuermann, president and CEO of Saluda Medical, will deliver the keynote address -

ENewsChannels NEWS: -- Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that several promising neurotechnology startups and early-stage firms will present at the 2023 Neurotech Leaders Forum in San Francisco, November 6-7. The 23rd annual event-the most established in the industry-will also feature presentations and panel discussions on important issues confronting the neurotechnology industry. :: News from eNewsChannels

  The Ghana Revenue Authority (GRA) compliance and enforcement unit has closed down four businesses for failure to issue Value...

The Ghana Revenue Authority (GRA) compliance and enforcement unit has closed down four businesses for failure to issue Value Added Tax (VAT) invoices of the Authority.  The GRA expects that all suppliers of taxable items, goods or services to issue VAT invoice as required by law while the customer is…

Researchers suggest physician exhaustion lowers empathy levels.

Physicians who are sleep deprived have less empathy for a patients pain complaints and prescribe fewer analgesics, new research suggests.

Israeli oncologist and neuroscientist collaborate on multisensory gadgets to enhance hope and wellbeing for cancer patients, families and staff.

Shaare Zedek Medical Center's new radiotherapy center promotes hope by stimulating the senses.